1993
DOI: 10.1006/gyno.1993.1137
|View full text |Cite
|
Sign up to set email alerts
|

HPV, HIV Infection, and Risk of Cervical Intraepithelial Neoplasia in Former Intravenous Drug Abusers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
18
2
4

Year Published

1994
1994
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 68 publications
(25 citation statements)
references
References 0 publications
1
18
2
4
Order By: Relevance
“…The prevalence of SIL among our HIV‐infected patients was 49.4%, and this figure is slightly higher than that previously reported by other Italian investigators—42.1% by Conti et al [20] and 35.5% by Cappiello et al [8]. In our study population, HGSIL prevalence in relation to CD4+ cell counts was significantly higher among women with <500 CD4+ cells/mm 3 ( p = .02), but no significant difference emerged in relation to viral load as it occurred in 22.7% (5 of 22) of women with> 100,000 copies/mL and in 18.2% (20 of 110) of those with <100,000 copies/mL.…”
Section: Discussioncontrasting
confidence: 70%
“…The prevalence of SIL among our HIV‐infected patients was 49.4%, and this figure is slightly higher than that previously reported by other Italian investigators—42.1% by Conti et al [20] and 35.5% by Cappiello et al [8]. In our study population, HGSIL prevalence in relation to CD4+ cell counts was significantly higher among women with <500 CD4+ cells/mm 3 ( p = .02), but no significant difference emerged in relation to viral load as it occurred in 22.7% (5 of 22) of women with> 100,000 copies/mL and in 18.2% (20 of 110) of those with <100,000 copies/mL.…”
Section: Discussioncontrasting
confidence: 70%
“…Given that invasive cervical cancer is preceded by gradual progression of premalignant CIN, 41-44 our findings highlight the importance of cervical screening upon entry into care to optimize the potential for early interventions and cure. This is essential among WLWH, given the higher prevalence of CIN 11,13 and the worse treatment outcomes among this population compared with HIV-negative women. 45-47 …”
Section: Discussionmentioning
confidence: 99%
“…This is because of the synergistic effects of a nation that is heavily burdened with HIV 6,7 and poor access to adequate diagnostic screening for precancerous lesions. 8-10 Women living with HIV (WLWH) have been shown to be at increased susceptibility for the development of precancerous lesions, 11-13 including both high-grade squamous intraepithelial lesions (HSILs) and cervical intraepithelial neoplasia (CIN), 14-16 and cervical cancer. 13,17-20 Unfortunately, most do not receive adequate screening, 21-24 despite recommendations made in 2014 that promote annual screening among WLWH.…”
Section: Introductionmentioning
confidence: 99%
“…For women living with HIV, the accuracy of cytology and colposcopy are critical to the timely diagnosis and treatment of cervical precancer as part of cancer prevention efforts. Rates of cervical intraepithelial neoplasia (CIN) are higher among those infected with HIV than among uninfected women [1, 2, 3, 4, 5]. The prevalence of abnormal cytology among HIV‐seropositive women is 38%[6], and current guidelines suggest intensive cytologic screening for women with HIV [7].…”
Section: Introductionmentioning
confidence: 99%